Erlotinib Promising for Cancer Prevention in FAP ...Middle East

Medscape - News
Findings from this phase 2 trial support further study of erlotinib as "an effective, acceptable cancer preventive agent for FAP-associated gastrointestinal polyposis," the study team says. Medscape Medical News

Hence then, the article about erlotinib promising for cancer prevention in fap was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Erlotinib Promising for Cancer Prevention in FAP )

Apple Storegoogle play

Last updated :

Also on site :



Latest News